Category Archives: News and Publications

  • 0

Women with Breast Cancer are more Likely to have High Blood Levels of Pesticides – London Owen Dyer

Women with breast cancer are more likely to show high serum concentrations of organochlorine pesticides, such as DDT, which are known oestrogenic compounds, a study has found ( Occupational and Environmental Medicine 2003;60:348-51).

The researchers, at the Sart Tilman Hospital in Liège , Belgium , tested 159 women who had had positive diagnoses of breast cancer, while 250 controls were randomly selected from women without known cancers who were attending for routine vaginal cytological examinations. At least one control was matched to each woman with breast cancer, for factors such as age, reproductive status, and menopause. The proportion of smokers was similar in the two groups, as were the proportions of urban dwellers and of breast feeders.

The women were tested for two organochlorines, dichlorodiphenyltrichloroethane (DDT) and hexachlorobenzene (HCB). The total burden of DDT was calculated by adding up all isomers of DDT and its metabolite. The mean concentration of DDT was significantly higher in the women with breast cancer than in controls (3.94 versus 1.83 parts per billion; P<0.0001). The same was true of HCB (0.79 versus 0.09 parts per billion; P=0.0005).

Patients with levels of DDT above 0.5 parts per billion in their blood were five times more likely to be cases than controls (95% confidence interval 1.81 to 17.65), while for those with more than than 0.5 parts per billion of HCB the risk was increased by a factor of nine (95% CI 2.84 to 29.41).

While the findings were significant, the authors were cautious about drawing the obvious conclusion that organochlorine pesticides increase the risk of breast cancer.

Since the postulated mechanism is oestrogenic, it might be expected that women with tumours that tested positive for oestrogen receptor status would have the highest levels of pesticide exposure. However, no such correlation was found. Neither was there a correlation between tumour size and organochlorine burden. Several studies have looked at organochlorines and breast cancer in the past, but the only meta-analysis concluded that no link was proved.

Richard Sullivan, head of clinical programmes at Cancer Research UK , said the study had merit but had neglected to control for important factors such as family history and hormone replacement therapy. “In a sense the number of factors that can be controlled for is limited by the study’s size. It’s certainly not the definitive study that proves the case. In the pantheon of environmental carcinogens oestrogen still ranks pretty low.”

DDT has been banned in Europe and North America for decades but can remain in human tissue for up to 50 years. The highest concentration detected in this study was 20 parts per billion, much lower than in some previous studies. “This kind of environmental research remains essential,” said Dr Sullivan, “but fortunately this particular study is more a lesson from history than a warning of a future threat.”


  • 0

The Cause and Prevention of Cancer – Saul Pressman

We now understand the chemical mechanisms of respiration and fermentation at the cellular level. And due to the work of Dr. Otto Warburg, since 1926 we have known that when a cell is deprived of oxygen, down to about 40% of normal, its respiration is irreversibly damaged. This damage causes the cell to begin to ferment sugar anaerobically producing carbon monoxide and lactic acid, and only 1/6 of the energy of normal cellular aerobic oxidation. The cell loses its governor on growth and begins to grow wildly – – what we call cancer.

This oxygen deficiency, or hypoxia, can be caused by many factors. Some poison may reach the cell and prevent oxygen uptake, or the excretory duct of a gland may become plugged up, as in breast cancer being cause by lymph gland plugging. But the end result is the same. As soon as the oxygen level to the cell is reduced, if the cell does not die, cancer will result. Frequent small doses of respiratory poisons are therefore more dangerous than a single large dose, where there is the chance that the cells will be killed rather than become cancerous.

All carcinogens impair cellular respiration. The word carcinogen is an empty word. The continual search for more carcinogenic substances is an utter waste of time and money, because this obscures the true cause of cancer, which is the oxygen starvation of the cell. It also prevents the treatment of cancer, because of misunderstanding the cause.

To destroy cancer, what is required is the introduction of massive amounts of oxygen at the cellular level. This can be done by ingesting magnesium peroxide or introducing ozone. These two treatments have been in use for over 75 years, with excellent success. They must be taken in sufficient quantities to flood the cells with oxygen, killing the cells which are now operating anaerobically.

Oxygen is the most vital element required for human life and it is the key to good health. We can survive without water for a week and go without food for a month, but we can only live a few minutes without oxygen. Oxygen is the life-giving, life-sustaining element. All body activities require oxygen. Through oxidation, the body generates heat and energy from its fuel, and disposes of wastes and microbes. Our bodies are two-thirds water. Of that water, ten per cent is blood and ninety per cent is lymph. Since the water in our bodies is itself 8/9 oxygen by weight, we are therefore composed of over 50% oxygen. The best way to optimize health is to oxygenate every cell in our body. The more oxygen we have in our system, the more energy we produce, and the more efficiently we can eliminate wastes. Good health is dependent on the production, maintenance and flow of energy, which is produced by the oxidation of sugar. Oxidation is central to metabolism, circulation, respiration, digestion, assimilation and elimination. Oxygen purifies the blood, keeping it free of cellular waste buildup. Sufficient oxygen allows the body to rebuild itself and maintain the immune system. Healthy cells require sugar, amino acids, minerals, hormones, enzymes and oxygen.

The Cause of Cancer

The link between insufficient oxygen and disease has been firmly established. Insufficient oxygen can result in anything from mild fatigue to life-threatening disease. Dr. Otto Warburg was awarded the Nobel Prize in 1931 and again in 1944 for discovering the cause of cancer. He said, “Cancer has only one prime cause. The prime cause of cancer is the replacement of normal oxygen respiration of body cells by an anaerobic (oxygen-less) cell respiration.” Once the level of oxygen available to a cell drops below 60% of normal, the cell is forced to switch to an inferior method of energy production — fermentation. The cell can never be returned to the proper oxidation system, and loses its governor on replication. It begins to reproduce copies of itself wildly, a condition we call cancer. Dr. Warburg pointed out that any substance that deprived a cell of oxygen was a carcinogen, if the cell was not killed outright. He stated in 1966 that it was useless to search out new carcinogens, because the result of each one was the same, cellular deprivation of oxygen. He further stated that the incessant search for new carcinogens was counter-productive because it obscured the prime cause, lack of oxygen, and prevented appropriate treatment.

Confirmation of Dr. Warburg’s Work

The National Cancer Institute endorsed Dr. Warburg’s findings in 1952. This research was continued by Dr. Harry Goldbatt, who published his findings in the Journal of Experimental Medicine in 1953. His research confirmed that lack of oxygen plays the major role in causing cells to become cancerous. Dr. Albert Wahl said, “Disease is due to a deficiency in the oxidation process of the body, leading to an accumulation of toxins. These toxins are ordinarily burned in normal oxidation.” Dr. Wendell Hendricks of the Hendricks Research Foundation wrote: ” Cancer is a condition within the body where the oxidation has become so depleted that the body cells have degenerated beyond control. The body is so overloaded with toxins that it sets up a tumor mass to harbor these poisons and remove them from general activity within the body.” Dr. Hendricks further states, “The true cause of allergy is a lowered oxidation process within the body, causing the body to be sensitive to substances entering. Only when the oxidative mechanism is restored to a higher state of efficiency can the sensitivity be eliminated.” Dr. Stephen Levine stated, “Hypoxia, or the lack of oxygen in the tissues, is the fundamental cause of all degenerative diseases.”

Dr. Norman McVea said, “When the body has sufficient oxygen, it is able to properly eliminate toxic wastes from the system. Natural immunity is enhanced when the system is not burdened with a heavy buildup of toxins.”

In the August 22, 1980 edition of the scientific journal “SCIENCE,” Vol. 209, there was a report written by DR. Michael Carpendale entitled: “Ozone Selectivity Inhibits Growth of Human Cancer Cells.” It stated, in part, ” The growth of human cancer cells from lung, breast and uterine cancers was selectively inhibited in a dose-dependent manner by ozone at 0.3 to .8 parts per million of ozone in ambient air during eight days of culture. Human lung diploid fibro-blasts served as non-cancerous control cells. The presence of ozone at 0.3 to 0.5 parts per million inhibited cancer cell growth at 40 and 60% respectively. The non-cancerous lung cells were unaffected at these levels. Exposure to ozone at 0.8 parts per million inhibited cancer cell growth more than 90% and control cell growth less than 50%. Evidently the mechanisms for defense against ozone damage are impaired in human cancer cells.”

The evidence from these doctors’ research is conclusive. Oxygen plays the primary role in health and well-being. It is important to note that fear, worry and depression all interfere with free breathing and thus reduce oxygen uptake.


  • 0

Cancer Research

By Dr. H. Gonzalez N.D., Ph.D. Msc.D., N.C., C.R.A. Editor and publisher.

Dr. H. Gonzalez began Cancer research in 1978 when his wife died with CANCER.
On March 28, 1996, Doctor Gonzalez Ph.D., was invited by the American Cancer Society to give a lecture on “Unorthodox Cancer Treatments” at Flager Hospital in the Psychiatric Center, San. Augustine, Florida.This video lecture is available. Send a letter for more information to 10947 Hawaii Dr. S., Jacksonville, Florida 32246.

FOODS FOR CANCER PREVENTION
CANCER ALLOPATHIC AND HOLISTIC THERAPY
WHAT IS CANCER
TREATMENT PLANNING
ALLOPATHIC METHODS OF TREATING CANCER

SURGERY
RADIATION THERAPY
CHEMOTHERAPY

SIDE EFFECTS OF TREATMENT
HOLISTIC CANCER THERAPIES

OXYGEN THERAPY
ANTI-ANGIOGENESIS
HYPERTHERMIA
BIPOLAR THERAPY
NUTRITIONAL SUPPORT
TUMOR ENERGY DEPRIVATION
HERBS
ESSIAC

PREPARATION OF THE 4-HERB FORMULA
FLAXSEED OIL
THYMUS THERAPY
ARGININE
PHOTOLUMINESCENT THERAPY
METASTASIS PREVENTION
CANCER PATIENTS
HUMAN CANCER AND DNA REPAIR DEFICIENT DISEASES
DNA MUTATIONS AND CANCER
CANCER GENES
GENE THERAPY
LABORATORY RESEARCH
CELL CULTURE STUDIES
ANIMALS IN CANCER RESEARCH
EPIDEMIOLOGISTS ON THE JOB
CANCER STATISTICS
ENETICS
CANCER TREATMENT
RADIATION TREATMENT
GENE THERAPY
PETS AND CANCER
CANCER PREVENTION
SMOKING & NUTRITION
DIET AND CANCER
DIET STRATEGIES
GENETICS
GENE STRUCTURE
SOMETHING TO THINK ABOUT!
ESSIAC Formula

 


  • 0

Researchers seek to solve mystery of natural HIV control

In search of new vaccine strategies, study will examine genetics, immune systems of those able to suppress viral replication

An international, multi-institutional research consortium is seeking to discover how a few HIV-infected individuals are naturally able to suppress replication of the virus. The Elite Controller Collaborative Study (http://www.mgh.harvard.edu/aids/hiv_elite_controllers.asp), the first large-scale haplotype-mapping study in people infected with HIV, is searching for genetic factors that may explain these individuals’ unique ability to control the virus without treatment, sometimes as long as 25 years after infection.

“If we could discover how these individuals can coexist with this virus without damage to their immune system and could find a way to replicate that ability in others, we would have a recipe for halting the HIV epidemic,” says Bruce Walker, MD, director of Partners AIDS Research Center (PARC) at Massachusetts General Hospital and an initial organizer of the Elite Controller Collaborative Study. Walker discussed the project in a media briefing today at the 16th International AIDS Conference in Toronto.

Most people infected with HIV cannot control replication of the virus with their immune systems alone. Unless antiviral medications are used, the virus continues to reproduce until it overwhelms the CD4 T helper cells, suppressing the immune response and leading to AIDS. In the early 1990s, it was recognized that a small minority of HIV-positive people remained healthy and did not progress to AIDS despite many years of infection. The term “long-term nonprogressors” was used to refer to this group. With today’s more sensitive techniques for measuring viral levels in the bloodstream, individuals who are able to maintain low levels of HIV replication can be identified soon after their infection is diagnosed. Some of these viremic controllers can maintain viral loads below 2,000 copies/ml, while an even smaller group, called elite controllers, have viral loads too low to be detected by currently available assays.

“The primary goal of the Elite Controller Collaborative Study is to identify the mechanism that explains control of viral replication in both of these groups, ” says Florencia Pereyra, MD, of PARC, lead coordinator of the research team. “We want to use that knowledge to develop a first-generation HIV vaccine, which may not cure or prevent infection but could successfully suppress viral levels. Since this natural ability is so rare, we need to work with collaborators around the world to recruit the number of participants we will need to determine what is going on.

“We expect to need data from at least 1,000 such individuals in order to define the genetic factors associated with this extraordinary outcome,” she adds. “This effort will only be possible with the collaboration of HIV researchers, providers, advocacy groups and most important the HIV-infected individuals that fall in this category.”

Those eligible to participate in the Elite Controller Collaborative Study are HIV-positive adults, aged 18 to 75, who have maintained viral loads below 2,000 copies without taking HIV antiviral medications. Participation involves having a single blood sample taken, which can be done by participants’ local healthcare providers. Those located near a participating research center may choose to be followed over time and provide additional blood samples.

“So far we have enrolled nearly 200 participants from 25 U.S. states, and we are looking forward to adding participants from other countries,” says Pereyra. Potential participants or collaborating providers seeking more information should contact Rachel Rosenberg, Partners AIDS Research Center, (617) 726-5536 or rrosenberg2@partners.org.

###

In addition to Walker, other organizers of the Elite Controller Collaborative Study are Eric Lander, PhD, director of the Broad Institute of Harvard University and Massachusetts Institute of Technology; Dennis Burton, PhD, of the Scripps Institute; Steven Deeks, MD, University of California at San Francisco; and Mary Carrington, PhD, of the U.S. National Cancer Institute. The current list of consortium members is on the next page. The project is supported by a philanthropic gift from the Mark and Lisa Schwartz Foundation.

The Partners AIDS Research Center, the project’s coordinating center, was established in 1995 in response to the continuing world-wide AIDS pandemic. The center serves both Massachusetts General Hospital and Brigham and Women’s Hospital, the founding members of Partners HealthCare, and is a natural progression of the more than 20-year commitment by the clinicians and scientists at those institutions to HIV and AIDS research and care. The center’s scope has broadened further with the participation of the Dana Farber/Partners Cancer Center regarding AIDS oncology and close collaborative ties to Fenway Community Health Center and the Lemuel Shattuck Hospital.

Elite Controller Collaborative Study

Participating institutions, as of August 14 2006Investigators
Partners AIDS Research Center/Massachusetts General HospitalBruce Walker, MD
Boston, Mass. (coordinating center)Florencia Pereyra, MD
Aaron Diamond AIDS Research Center, New York, N.Y.Martin Markowitz, MD
Centre Hospitalier de l’Université de Montreal, QuebecCécile Tremblay, MD
Duke University, Durham, N.C.Barton Haynes, MD
Fred Hutchinson Cancer Research Center, Seattle, Wash.M. Juliana McElrath, MD, PhD
Imperial College, London, U.K.Jonathan Weber, MD
McGill University Health Center, MontrealNicole Bernard, PhD
Northwestern University, Chicago, Ill.Robert Murphy, MD
Sanquin Blood Supply Foundation, Amsterdam, NetherlandsHanneke Schuitemaker, PhD
University of California at Los AngelesOtto Yang, MD
University of California at San DiegoDouglas Richman, MD
University of California at San FranciscoSteven Deeks, MD
University of New South Wales AustraliaJohn Kaldor, PhD Tony Kelleher, MD, PhD
Venderbilt University, Nashville, Tenn.Spyros Kalams, MD
Weill Medical College of Cornell University, New York, N.Y.John P. Moore, PhD

Other collaborating organizations:

AIDS Action Committee, Boston
AIDSmeds.com
AIDS Vaccine Advocacy Coalition (AVAC)
TheBody.com
Center for AIDS Information and Advocacy, Houston
Gay Men’s Health Crisis, New York
International AIDS Society – USA
International AIDS Vaccine Inititative
Los Angeles Gay and Lesbian Center
Physicians’ Research Network (PRN), New York
POZ magazine
Test Positive Aware Network, Chicago
Treatment Action Group, New York
Also more than 100 health care providers worldwideM

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital


  • 0

Dring Your Allergy Shots!!!

Are you suffering with allergies, asthma, eczema, or other allergy related symptom? Do sinus infections haunt you on are regular basis? Does the taught of injections keep you away from your physician? Now you can sip your allergy serum with sublingual immunotherapy (SLIT).

While injection therapy requires frequent, time-consuming trips to the doctor for shots, SLIT provides a pleasant and effective alternative. Serum is dosed as drops under the tongue, absorbing into the bloodstream through tiny capillaries in the mouth-all in the comfort of your own home.

SLIT was developed in the 1980’s. It has been endorsed by the World Health Organization and more than 50 scientific studies have confirmed its safety and effectiveness. Many allergy sufferers seek sublingual allergy therapy because they do not have to visit an office for shots; they can take serum more frequently which leads to rapid results. It has been well documented that with SLIT, 80 percent of patients experience relief in less than three months. Injection therapy commonly requires a year or two to produce results. SLIT success rates are even higher for asthma problems with 90 percent of asthmatics achieving symptom relief in just a few months.

Patients share their experiences and often relate that prior to SLIT the first traces of the spring season would stir up allergy symptoms causing them relentless hay fever and asthma. Many would combat symptoms with expensive prescription allergy and asthma medications that would never get to the source of the problem. Some of them try allergy shots and found that they were time consuming and too pricey. This led many of these patients to address their allergies with SLIT. The therapy starts with a brief allergy test, and a vial of serum to protect him or her from the country’s major allergens. Patients utilizing SLIT found that when spring rolled around they were able to weather the season without any significant allergy or asthma flare-ups, and they continue to swear by the program.

It is found that SLIT works well for a number of groups not often helped by traditional allergy and asthma treatment programs including allergy shots. Many allergists don’t treat children until about age seven because of the regular regimen of shots. With sublingual administration, the physician can test and treat even young toddlers. Frequent travelers and winter visitors also benefit thanks to the portable serum.

Allergies continue to be a growing problem in Arizona, forcing more residents to grapple with allergy treatment options. Once heralded as a refuge from allergies due to its warm, dry climate, Arizona has fallen from grace at the hands of its burgeoning population. As newcomers have poured into the state, they have imported their favorite trees and grasses, many of which have turned Arizona into an allergy hotbed. The Asthma and Allergy Foundation of America (AAFA) ranked the general Metro-Phoenix area the18th most challenging place to live with allergic asthma in 2006. And the AAFA consistently ranks Phoenix among the country’s top 100 allergy capitals.

Paul Stallone, NMD founded the Arizona Integrative Medical Center located at 8144 East Cactus Road, Suite 820 in Scottsdale. Dr. Stallone uses Allergyeasy (SLIT) and combines Natural / Alternative / Conventional treatments to best fit and benefit each individual patient’s needs. For more information please visit his office on the web at www.drstallone.com or call the office at 480-214-3922.


Consultation Request

Name

Phone

Email

Service of Interest (Required)

How did you hear about us?

PayPal